Skip to search boxSkip to navigationSkip to main content

EVI5 is a novel centrosomal protein that binds to α- and γ-tubulin

  • Silviu L. Faitar
    ,
  • Jeremy T.S. Dabbeekeh
    ,
  • Tamara A. Ranalli
    ,
  • John K. Cowell(corresponding author)
*Corresponding author for this work
  • Roswell Park Cancer Institute
Scholary Output:
Contribution to journal
Article
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

The human EVI5 protein carries a TBC domain indicative of Rab GTPase activating protein (GAP) activity, and an extensive coiled-coil motif in the C-terminal region. EVI5 is ubiquitously expressed in adult, fetal, and cancer tissues and exists as two mRNA species resulting from differential use of polyadenylation signals. Western blot analysis suggests that different molecular weight protein species are probably generated by posttranslational modification. FPLC analysis demonstrates that EVI5 protein can form dimers and confocal microscopy indicates that EVI5, in addition to a diffuse localization in the nucleus, also preferentially localizes to the pericentriolar material in interphase cells. Immunoprecipitation and GST pull-down experiments demonstrate that EVI5 exists in complexes with both α- and γ-tubulin. Both interactions are localized to the N-terminal part of the EVI5 protein. Thus, EVI5 is a novel centrosomal protein with a complex expression pattern and subcellular localization, possibly involved in centrosome stability and dynamics.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 594-605 (12 pages)

Journal (Volume, Issue Number)

Genomics (Volume 86, Issue 5)

Publication milestones

  • Published - 11/2005

Publication status

Published - 11/2005

ISSN

0888-7543

Publication IDs

  • Scopus: 26244457616
  • PubMed: 16033705

Publication metrics

Metrics

SciVal
citations
19
Scopus
citations
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1
SciVal
FWCI
0.46
SciVal
Author count
4
SciVal
Paper percentile
72

PlumX, opens in new tab

Citation count
22
Captures
26
Mentions
2

Funding Details

We are grateful to Dr. Robert Somerville for assistance with the expression studies, and to Dr. Jennifer Black and Mr. Edward Hurley for immunocytochemistry and confocal assistance, respectively. This work was supported by Grant NS 35791 from the National Institutes of Health and in part by the National Cancer Institute Roswell Park Cancer Center Support Grant, CA 16056.
FundersFunding number
NIH
-
NCI
P30CA016056
RPCI
-